192 related articles for article (PubMed ID: 15072706)
1. Methimazole-induced aplastic anemia caused by hypocellular bone marrow with plasmacytosis.
Yamamoto A; Katayama Y; Tomiyama K; Hosoai H; Hirata F; Kimura F; Fujita K; Yasuda H
Thyroid; 2004 Mar; 14(3):231-5. PubMed ID: 15072706
[TBL] [Abstract][Full Text] [Related]
2. Massive plasmocytosis due to methimazole-induced bone marrow toxicity.
Breier DV; Rendo P; Gonzalez J; Shilton G; Stivel M; Goldztein S
Am J Hematol; 2001 Aug; 67(4):259-61. PubMed ID: 11443640
[TBL] [Abstract][Full Text] [Related]
3. Methimazole-induced aplastic anemia in third exposure: successful treatment with recombinant human granulocyte colony-stimulating factor.
Mezquita P; Luna V; Muñoz-Torres M; Torres-Vela E; Lopez-Rodriguez F; Callejas JL; Escobar-Jimenez F
Thyroid; 1998 Sep; 8(9):791-4. PubMed ID: 9777751
[TBL] [Abstract][Full Text] [Related]
4. Methimazole-induced severe aplastic anemia: unsuccessful treatment with recombinant human granulocyte-monocyte colony-stimulating factor.
Escobar-Morreale HF; Bravo P; García-Robles R; García-Laraña J; de la Calle H; Sancho JM
Thyroid; 1997 Feb; 7(1):67-70. PubMed ID: 9086574
[TBL] [Abstract][Full Text] [Related]
5. [Severe aplastic anemia as a complication of treatment with metizol].
Swider G; Grzywa M; Zuzak Z
Wiad Lek; 1996; 49(7-12):136-9. PubMed ID: 9245107
[TBL] [Abstract][Full Text] [Related]
6. Transient methimazole-induced bone marrow aplasia: in vitro evidence for a humoral mechanism of bone marrow suppression.
Moreb J; Shemesh O; Shilo S; Manor C; Hershko C
Acta Haematol; 1983; 69(2):127-31. PubMed ID: 6188311
[TBL] [Abstract][Full Text] [Related]
7. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily.
Takata K; Kubota S; Fukata S; Kudo T; Nishihara E; Ito M; Amino N; Miyauchi A
Thyroid; 2009 Jun; 19(6):559-63. PubMed ID: 19445623
[TBL] [Abstract][Full Text] [Related]
8. Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism.
Sato S; Noh JY; Sato S; Suzuki M; Yasuda S; Matsumoto M; Kunii Y; Mukasa K; Sugino K; Ito K; Nagataki S; Taniyama M
Thyroid; 2015 Jan; 25(1):43-50. PubMed ID: 25178068
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of antithyroid drug-induced aplastic anemia cases over the past 30 years.
Cheng Y; Xia XY; Zhang W; Ren L; Tian CF; Liu D; Xue G
Front Endocrinol (Lausanne); 2023; 14():1064723. PubMed ID: 36777352
[TBL] [Abstract][Full Text] [Related]
10. Acute pancreatitis induced by methimazole in a patient with Graves' disease.
Yang M; Qu H; Deng HC
Thyroid; 2012 Jan; 22(1):94-6. PubMed ID: 22136208
[TBL] [Abstract][Full Text] [Related]
11. Antithyroid drug-induced aplastic anemia.
Thomas D; Moisidis A; Tsiakalos A; Alexandraki K; Syriou V; Kaltsas G
Thyroid; 2008 Oct; 18(10):1043-8. PubMed ID: 18816182
[TBL] [Abstract][Full Text] [Related]
12. [Bone marrow aplasia and liver damage caused by methimazole].
Undas A; Dreger B; Skałuba Z; Musiał J
Pol Arch Med Wewn; 1998 Jun; 99(6):493-6. PubMed ID: 10085704
[TBL] [Abstract][Full Text] [Related]
13. Use of antihistamines after serious allergic reaction to methimazole in pediatric Graves' disease.
Toderian AB; Lawson ML
Pediatrics; 2014 May; 133(5):e1401-4. PubMed ID: 24777217
[TBL] [Abstract][Full Text] [Related]
14. Remission of aplastic anemia induced by treatment for Graves disease in a pediatric patient.
Das PK; Wherrett D; Dror Y
Pediatr Blood Cancer; 2007 Aug; 49(2):210-2. PubMed ID: 16456859
[TBL] [Abstract][Full Text] [Related]
15. Acute pancreatitis and parotitis induced by methimazole in a patient with Graves' disease.
Taguchi M; Yokota M; Koyano H; Endo Y; Ozawa Y
Clin Endocrinol (Oxf); 1999 Nov; 51(5):667-70. PubMed ID: 10594530
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of methimazole-induced severe aplastic anaemia in a diabetic patient with other co-morbidities.
Josol CV; Buenaluz-Sedurante M; Sandoval MA; Castillo G
BMJ Case Rep; 2010 Dec; 2010():. PubMed ID: 22802368
[TBL] [Abstract][Full Text] [Related]
17. Morning granulocytopenia in a case of Graves' disease.
Nakamura S; Isaji M; Ishimori M
Endocr J; 2001 Apr; 48(2):181-4. PubMed ID: 11456265
[TBL] [Abstract][Full Text] [Related]
18. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
19. Agranulocytosis, plasmacytosis, and thrombocytosis due to methimazole-induced bone marrow toxicity.
Oh EJ; Chae HJ; Park YJ; Park JW; Han K
Am J Hematol; 2007 Jun; 82(6):500. PubMed ID: 17266051
[No Abstract] [Full Text] [Related]
20. [Fever due to antithyroid agents].
Shamelian SO; Nortier JW
Ned Tijdschr Geneeskd; 1999 Jan; 143(5):225-8. PubMed ID: 10086149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
